Healthcare Services Group (HCSG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Feb, 2026Executive summary
Full-year revenue reached $1.84 billion, up 7.1% year-over-year, with Q4 revenue at $466.7 million, up 6.6% from the prior year.
Net income for the year was $59.1 million ($0.81 EPS), and $31.2 million ($0.44 EPS) for Q4, including an $8.3 million ($0.12 per share) tax benefit from ERC receipts.
Cash flow from operations totaled $145.0 million for the year and $17.4 million for Q4; adjusted for payroll accrual, $164.1 million and $36.4 million, respectively.
Completed a $50 million share repurchase plan five months early; $61.6 million repurchased in 2025.
Industry fundamentals remain strong, supported by demographic trends and stable operating conditions.
Financial highlights
Environmental Services segment revenue was $210.8 million with a 12.6% margin; Dietary Services revenue was $255.9 million with a 7.2% margin in Q4.
Cost of services for Q4 was $394.6 million (84.6% of revenue); SG&A was $46.2 million (9.8% of revenue, adjusted).
Cash and marketable securities at year-end totaled $203.9 million; $300 million credit facility undrawn.
Effective tax rate was a 9.4% benefit for Q4 and 13.0% expense for the year, including an $8.3 million benefit from Employee Retention Credits.
Adjusted EBITDA for the year was $82.6 million (4.5% of revenue), up from $76.3 million (4.4%) in 2024.
Outlook and guidance
2026 revenue expected to grow at a mid-single-digit rate, with Q1 revenue projected at $460–$465 million and sequential growth through the year.
Cost of services targeted at 86% of revenue; SG&A targeted at 9.5–10.5%, with a longer-term goal of 8.5–9.5%.
Effective tax rate for 2026 expected to be approximately 25%.
Net income expected to remain a strong proxy for cash flow from operations.
Latest events from Healthcare Services Group
- Q2 revenue rose 1.8% to $426.3M, but a large bad debt charge drove a net loss of $1.8M.HCSG
Q2 20243 Feb 2026 - Q3 2024 revenue and net income grew, with strong cash flow and reaffirmed guidance.HCSG
Q3 202419 Jan 2026 - Q1 2025 saw record revenue, higher net income, and raised cash flow guidance.HCSG
Q1 202523 Dec 2025 - Q4 revenue grew to $437.8M, but net income and margins fell; 2025 growth expected.HCSG
Q4 202423 Dec 2025 - 2024 saw growth, high retention, and strong governance, with key votes on directors, pay, and audit.HCSG
Proxy Filing1 Dec 2025 - Q2 revenue up 7.6%, $61.2M charge drives $32.4M loss, $50M buyback and higher cash flow planned.HCSG
Q2 202516 Nov 2025 - Q3 revenue up 8.5% to $464.3M, net income $43M, aided by ERC refunds and strong segment growth.HCSG
Q3 202524 Oct 2025